Allarity Therapeutics, Inc.
ALLR
$1.28
$0.032.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -46.77% | -0.66% | 54.74% | 75.79% | -42.42% |
| Total Depreciation and Amortization | 183.33% | -336.36% | 700.00% | -980.00% | 1,100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 388.26% | 39.13% | 1,436.79% | -97.37% | 111.83% |
| Change in Net Operating Assets | 88.33% | -1,224.16% | -129.76% | 77.26% | 4.68% |
| Cash from Operations | 53.22% | -67.27% | -1.15% | 37.35% | 24.96% |
| Capital Expenditure | -- | -- | 97.32% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 97.32% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -99.98% | -94.24% | -54.86% | -100.00% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | 77.15% | -105.67% | -52.55% | -109.75% |
| Foreign Exchange rate Adjustments | 85.62% | 79.72% | 278.17% | 199.49% | -2,110.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.41% | 85.11% | -306.36% | -17.66% | -152.34% |